Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:32 UTC |
---|
HMDB ID | HMDB0001229 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Dopaquinone |
---|
Description | Dopaquinone, also known as o-dopaquinone or L-dopaquinone, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha-amino acids which have the L-configuration of the alpha-carbon atom. Dopaquinone is slightly soluble (in water) and a moderately acidic compound (based on its pKa). L-Dopaquinone is a metabolite of L-DOPA and a precursor of melanin. Melanin is synthesized from tyrosine by hydroxylation to dihydroxyphenylalanine (DOPA) and subsequent oxidation to dopaquinone. Both reactions are catalyzed by the enzyme tyrosinase, which is the rate-limiting step. Dopaquinone has an ortho-quinone ring, which is known to be neurotoxic and highly reactive with many other compounds (PMID: 413870 ). Dopaquinone typically combines with cysteine to form pheomelanin (a pigment-polymer). Alternatively, dopaquinone can be converted to leucodopachrome and eventually to eumelanin (also a pigment-polymer). Dopaquinone can be found in skin and feces. Within the cell, dopaquinone is primarily located in the cytoplasm. Dopaquinone is involved in several metabolic disorders, some of which include transient tyrosinemia, hawkinsinuria, tyrosinemia type I, and alkaptonuria. Chronically high levels of dopaquinone are associated with Parkinson's disease (PD). Many Parkinson's patients are treated with L-DOPA. However, long-term treatment with L-DOPA may actually worsen symptoms or result in neurotic and psychotic symptoms. These may be due to dopachrome and dopaquinone accumulating in the brain of L-DOPA treated patients (PMID: 19131041 , PMID: 12373519 ). |
---|
Structure | N[C@@H](CC1=CC(=O)C(=O)C=C1)C(O)=O InChI=1S/C9H9NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6H,3,10H2,(H,13,14)/t6-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(S)-2-Amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoate | ChEBI | (S)-2-Amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid | Generator | O-Dopaquinone | HMDB | 4-(2-Carboxy-2-aminoethyl)-1,2-benzoquinone | HMDB | Dopaquinone, (S)-isomer | HMDB | L-Dopaquinone | HMDB |
|
---|
Chemical Formula | C9H9NO4 |
---|
Average Molecular Weight | 195.1721 |
---|
Monoisotopic Molecular Weight | 195.053157781 |
---|
IUPAC Name | (2S)-2-amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid |
---|
Traditional Name | dopaquinone |
---|
CAS Registry Number | 4430-97-1 |
---|
SMILES | N[C@@H](CC1=CC(=O)C(=O)C=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C9H9NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6H,3,10H2,(H,13,14)/t6-/m0/s1 |
---|
InChI Key | AHMIDUVKSGCHAU-LURJTMIESA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- O-benzoquinone
- Quinone
- Ketone
- Amino acid
- Cyclic ketone
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Amine
- Hydrocarbon derivative
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Dopaquinone,1TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H](N)CC1=CC(=O)C(=O)C=C1 | 2063.1 | Semi standard non polar | 33892256 | Dopaquinone,1TMS,isomer #2 | C[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O | 2136.6 | Semi standard non polar | 33892256 | Dopaquinone,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O[Si](C)(C)C | 2162.5 | Semi standard non polar | 33892256 | Dopaquinone,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O[Si](C)(C)C | 2039.3 | Standard non polar | 33892256 | Dopaquinone,2TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O[Si](C)(C)C | 3018.7 | Standard polar | 33892256 | Dopaquinone,2TMS,isomer #2 | C[Si](C)(C)N([C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O)[Si](C)(C)C | 2268.6 | Semi standard non polar | 33892256 | Dopaquinone,2TMS,isomer #2 | C[Si](C)(C)N([C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O)[Si](C)(C)C | 2106.1 | Standard non polar | 33892256 | Dopaquinone,2TMS,isomer #2 | C[Si](C)(C)N([C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O)[Si](C)(C)C | 3121.6 | Standard polar | 33892256 | Dopaquinone,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC(=O)C(=O)C=C1)N([Si](C)(C)C)[Si](C)(C)C | 2276.6 | Semi standard non polar | 33892256 | Dopaquinone,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC(=O)C(=O)C=C1)N([Si](C)(C)C)[Si](C)(C)C | 2183.4 | Standard non polar | 33892256 | Dopaquinone,3TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@H](CC1=CC(=O)C(=O)C=C1)N([Si](C)(C)C)[Si](C)(C)C | 2949.5 | Standard polar | 33892256 | Dopaquinone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CC1=CC(=O)C(=O)C=C1 | 2328.9 | Semi standard non polar | 33892256 | Dopaquinone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O | 2387.6 | Semi standard non polar | 33892256 | Dopaquinone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2642.8 | Semi standard non polar | 33892256 | Dopaquinone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2501.2 | Standard non polar | 33892256 | Dopaquinone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3149.8 | Standard polar | 33892256 | Dopaquinone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2772.2 | Semi standard non polar | 33892256 | Dopaquinone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2535.4 | Standard non polar | 33892256 | Dopaquinone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC(=O)C(=O)C=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 3226.8 | Standard polar | 33892256 | Dopaquinone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC(=O)C(=O)C=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2996.1 | Semi standard non polar | 33892256 | Dopaquinone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC(=O)C(=O)C=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2809.2 | Standard non polar | 33892256 | Dopaquinone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@H](CC1=CC(=O)C(=O)C=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3101.0 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Dopaquinone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fml-5900000000-3f77b48d5f42d8951324 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dopaquinone GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9570000000-5d835cfbd2b202044cb7 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dopaquinone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 10V, Positive-QTOF | splash10-0ufs-0900000000-093c511b443d87916930 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 20V, Positive-QTOF | splash10-0ue9-1900000000-fc3bdef4314080b351c1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 40V, Positive-QTOF | splash10-0uxr-9200000000-07d0c6318c984ef80e41 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 10V, Negative-QTOF | splash10-0006-0900000000-7481c7c6fe6294da272c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 20V, Negative-QTOF | splash10-002f-0900000000-04347396e1171463fb62 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 40V, Negative-QTOF | splash10-00di-7900000000-13ce3640966908fffe55 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 10V, Negative-QTOF | splash10-0006-0900000000-c319fd057861dc7d7ad4 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 20V, Negative-QTOF | splash10-00e9-3900000000-b64033d6c2ec2ca4314b | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 40V, Negative-QTOF | splash10-00di-5900000000-cde5f7d52f36428ed06e | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 10V, Positive-QTOF | splash10-0udj-0900000000-2ca1383c9487e79be90a | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 20V, Positive-QTOF | splash10-0ff0-0900000000-92f4bf729acf4be5b6bf | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopaquinone 40V, Positive-QTOF | splash10-00e9-8900000000-d3972df871a20993fe05 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Rorsman H, Tegner E: Biochemical observations in UV-induced pigmentation. Photodermatol. 1988 Feb;5(1):30-8. [PubMed:3281148 ]
- Tsukamoto K, Furue M, Sato Y, Takayama O, Akasu R, Ohtake N, Wakamatsu K, Ito S, Tamaki K, Shimada S: Generalized melanosis in metastatic malignant melanoma: the possible role of DOPAquinone metabolites. Dermatology. 1998;197(4):338-42. [PubMed:9873171 ]
- Graham DG, Tiffany SM, Vogel FS: The toxicity of melanin precursors. J Invest Dermatol. 1978 Feb;70(2):113-6. [PubMed:413870 ]
- Hattoria N, Wanga M, Taka H, Fujimura T, Yoritaka A, Kubo S, Mochizuki H: Toxic effects of dopamine metabolism in Parkinson's disease. Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S35-8. doi: 10.1016/S1353-8020(09)70010-0. [PubMed:19131041 ]
- Kostrzewa RM, Kostrzewa JP, Brus R: Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Amino Acids. 2002;23(1-3):57-63. doi: 10.1007/s00726-001-0110-x. [PubMed:12373519 ]
|
---|